Stockscreener 앱 받기
70.27
1.87%
-1.34
시장 영업 전:
70.25
-0.02
-0.03%
전일 마감가:
$71.61
열려 있는:
$71.85
하루 거래량:
3.37M
Relative Volume:
0.58
시가총액:
$29.04B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
11.64
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
-3.77%
1개월 성능:
-8.94%
6개월 성능:
-39.39%
1년 성능:
-50.40%
1일 변동 폭
$69.93
$72.38
1주일 범위
$69.93
$73.55
52주 변동 폭
$69.93
$148.79
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
70.27 | 29.04B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
18.59 | 59.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
40.22 | 46.91B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
472.21 | 20.25B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance UK
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trading the Move, Not the Narrative: (ZTS) Edition - news.stocktradersdaily.com
Zoetis sets Nov 5 webcast for Q3FY26 earnings review - scanx.trade
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results - Business Wire
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis stock falls as TD Cowen cuts its target - AD HOC NEWS
Zoetis stock hits 52-week low at 70.97 USD - Investing.com
Zoetis Inc. (ZTS) Stock Analysis: Exploring A 34% Potential Upside For Investors - DirectorsTalk Interviews
The Best Healthcare Stocks to Buy - Morningstar
Zoetis Director Mark Stetter Acquires 342 Phantom Stock Units Under Deferred Compensation Plan - Kalkine Media
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note - finance.yahoo.com
Zoetis Stock: The Worst May Be Priced In (NYSE:ZTS) - Seeking Alpha
Stifel reiterates Zoetis stock rating at Hold on share concerns - Investing.com
Why this money manager bought UnitedHealth, Palantir and sold Zoetis - The Globe and Mail
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales - TradingView
Zoetis: Companion Animal Weakness Keeps Me On The Sidelines (NYSE:ZTS) - Seeking Alpha
Zoetis: An Undervalued Compounder Hiding In Plain Sight (NYSE:ZTS) - Seeking Alpha
Zoetis Stock: New Competition Changes The Story, But Not Yet The Rating (NYSE:ZTS) - Seeking Alpha
Zoetis Introduces Blood Parasite Detection and Enhanced Cell Classification to Vetscan Imagyst | Vet Candy News - Vet Candy
Zoetis Inc. (ZTS) - DirectorsTalk Interviews
Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors - ChartMill
Michael Burry Sells FLUT To Pile Into LULU Under $100 — Plus A New Bet On ZTS - TradingView
Why Are Zoetis (NYSE:ZTS) Diagnostics in S&P 500 Focus? - Kalkine Media
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Yahoo Finance
Zoetis Shares Slide Following Earnings RevisionEarnings Deceleration Risk - vinanet.vn
Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update - Moomoo
Zoetis Taps Former GE HealthCare CFO Jay Saccaro as CFO and COO - The Healthcare Technology Report.
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Paws and profits: Zoetis appoints global diagnostics president, NVA names chief medical officer, and more updates - DVM360
Zoetis (ZTS) Shares Drop After Earnings Revision - Yahoo Finance
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Is Zoetis Stock Underperforming the S&P 500? - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - BioSpace
Zoetis (ZTS) awards 81K stock units to its CFO - Stock Titan
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package - ChartMill
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Is It Too Late to Buy Zoetis Inc (ZTS) After 3.1% Rally? GF Value Says Undervalued - GuruFocus
A Look at Zoetis Inc (ZTS) After 3.2% Decline -- GF Value $180.6 - GuruFocus
The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio - simplywall.st
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - finance.yahoo.com
MS Global Franchise Portfolio's Bold Q2 2026 Move: Exits Zoetis Inc, a -2.6% Portfolio Impact - Yahoo Finance
Zoetis Inc. $ZTS Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Zoetis Updates Prescribing Information for FACTREL Cattle Injection - geneonline.com
ZTS Maintained by Stifel -- Price Target Lowered to $80 - GuruFocus
Stifel Nicolaus Has Lowered Expectations for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
Stifel cuts Zoetis stock price target on key franchise weakness - Investing.com
Stifel cuts Zoetis stock price target on key franchise weakness By Investing.com - Investing.com India
Meeder Asset Management Inc. Sells 42,497 Shares of Zoetis Inc. $ZTS - MarketBeat
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.52%
1.75%
자본화:
|
볼륨(24시간):